Therapeutic Group: Others Presentation Ajuben 6: Each tablet contains Deutetrabenazine INN 6 mg. Ajuben 12: Each tablet contains Deutetrabenazine INN 12 mg. Description The precise mechanism by which deutetrabenazine exerts its anti-chorea effects is unknown but is believed to be related to its effect as a reversible depletor of monoamines (such as dopamine, serotonin, norepinephrine, […]
Therapeutic Group: Topical Corticosteroid Presentation Desocort Cream: Each gram Cream contains Desoximetasone USP 2.5 mg. Description Desoximetasone is a corticosteroid having anti-inflammatory, anti-pruritic and vasoconstrictive actions. Indications Desocort Cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Dosage & Administration Apply a thin film of DesocortTMCream to the affected […]
Therapeutic Group: Contraceptive Presentation POP-D : Each tablet contains 0.075 mg Desogestrel. Description POP-D is a progestogen-only tablet, which contains the progestogen Desogestrel. Like other progestogen-only tablets, POP-D is best suited for use during breast feeding and for women who may not or do not want to use estrogens. In contrast to traditional progestogen-only tablets, […]
Therapeutic Group: Anti Histamine Presentation Neocilor tablet: Each film-coated tablet contains Desloratadine INN 5 mg. Neocilor syrup: Each 5 ml syrup contains Desloratadine INN 2.5 mg. Description Neocilor is a preparation of Desloratadine. Desloratadine is a long-acting tricyclic histamine antagonist with selective H1-receptor antagonist activity. It is a non-sedating antihistamine. Desloratadine has effects on the […]
Therapeutic Group: Monoclonal Antibody Presentation Denosis 120: Each ml solution for injection contains Denosumab 70 mg. Description Denosumab is a human IgG2 monoclonal antibody with affinity and specificity for human RANKL (receptor activator of nuclear factor kappa-B ligand). Denosumab binds to RANKL, a transmembrane or soluble protein essential for the formation, function, and survival of […]
Therapeutic Group: Monoclonal Antibody Presentation Denosis 60: Each pre-filled syringe contains 1 ml sterile solution of Denosumab 60 mg. Description Denosumab is a human IgG2 monoclonal antibody with affinity and specificity for human RANKL (receptor activator of nuclear factor kappa-B ligand). Denosumab binds to RANKL, a transmembrane or soluble protein essential for the formation, function, […]
Therapeutic Group: Antibiotic Presentation Delameg IV Infusion: Each vial contains Delafloxacin Meglumine INN equivalent to Delafloxacin 300 mg as lyophilized cake or powder. Description Delafloxacin is a fourth generation Fluoroquinolone with expanded activity against Gram positive bacteria including multidrug resistant strains of Streptococcus pneumoniae & Staphylococcus aureus (MRSA), as well as atypical pathogens. Like other […]
Therapeutic Group: Analgesic, Anti Inflammatory Presentation Deflazit 6 Tablet: Each tablet contains Deflazacort INN 6 mg. Deflazit 24 Tablet: Each tablet contains Deflazacort INN 24 mg Deflazit 50 ml Suspension: Each 5 ml Suspension contains Deflazacort INN 6 mg Deflazit 18 Tablet: Each tablet contains Deflazacort INN 18 mg. Description Deflazacort is an oxazoline derivative […]
Therapeutic Group: Kinase inhibitor Presentation Dasacentâ„¢ 50: Each film coated tablet contains Dasatinib monohydrate INN eqv. to Dasatinib 50 mg. Dasacentâ„¢ 100: Each film coated tablet contains Dasatinib monohydrate INN eqv. to Dasatinib 100 mg. Dasacentâ„¢ 140: Each film coated tablet contains Dasatinib monohydrate INN eqv. to Dasatinib 140 mg Description Dasatinib, at nanomolar concentrations, […]
Therapeutic Group: Drugs for Hematological Disorder Presentation Embardia 25 mcg Injection: Each pre-filled syringe contains Darbepoetin alfa INN 25 mcg in 0.42 ml solution for injection. Embardia 40 mcg Injection: Each pre-filled syringe contains Darbepoetin alfa INN 40 mcg in 0.40 ml solution for injection. Embardia 60 mcg Injection: Each pre-filled syringe contains Darbepoetin alfa […]